Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision identifier updated from v3.5.3 to v3.5.4, indicating a software update or patch was applied to the page; no substantive study details appear to be altered.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA minor update to the ClinicalTrials.gov page’s technical revision/version indicator (from v3.5.2 to v3.5.3) is displayed.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision history updated: v3.5.2 added and v3.5.0 removed.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded related topic 'Squamous cell carcinoma of the head and neck' and a Genetic and Rare Diseases Information Center (GARD) resource.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check66 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3. No substantive changes to study details or eligibility.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.